Key facts
- Notable investors include Vertex Ventures Southeast Asia & India, Kejora Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Filmore Pharma
- ·The full record, as it builds
Funding rounds
No funding rounds for Filmore Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Filmore Pharma
Developer of feminine care products designed to support reproductive and endocrine wellness. The company's offerings integrate patented innovations, skin-friendly formulations, and eco-conscious practices, providing products that are cruelty-free, hypoallergenic, and halal-certified, enabling women to experience effective, reliable, and advanced care suited to their requirements while promoting confidence and overall health.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Jakarta, Indonesia
- Founded
- 2021
- Employees
- 36
- Website
- filmorepharma.com/
- Ownership
- Privately Held (backing)
Filmore Pharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Filmore Pharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Filmore Pharma in its N-PORT filings yet. We sweep new filings monthly.